Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia

American Journal of Gastroenterology

Volumn 109, Issue 12, 2014, Pages 1910-1920

  Bharucha, Adil E ^a   Camilleri, Michael ^a   Burton, Duane D ^a   Thieke, Shannon L ^a   Feuerhak, Kelly J ^a   Basu, Ananda ^a   Zinsmeister, Alan R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; LIPID; PEPTIDE YY; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG INFUSION; DUODENAL NUTRIENT INFUSION; DUODENUM; DYSPEPSIA; ENTERIC FEEDING; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NAUSEA AND VOMITING; NEPEAN DYSPEPSIA INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH EMPTYING; BLOOD; CASE CONTROL STUDY; GLUCOSE INTOLERANCE; METABOLISM; SEVERITY OF ILLNESS INDEX;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; CHOLECYSTOKININ; DUODENUM; DYSPEPSIA; ENTERAL NUTRITION; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; LIPIDS; MALE; PEPTIDE YY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84925224208     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.330     Document Type: Article

References (48)

1. Feinle-Bisset C, Azpiroz F. Dietary and lifestyle factors in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 150-7.
2. Vanheel H, Farre R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142-9.
3. Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 187-94.
4. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006; 131: 640-58.
5. Lacy BE. Functional dyspepsia and gastroparesis: one disease or two? Am J Gastroenterol 2012; 107: 1615-20.
6. Barbera R, Feinle C, Read NW. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995; 40: 1636-41.
7. Barbera R, Feinle C, Read NW. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995; 7: 1051-7.
8. Feinle C, Meier O, Otto B et al. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001; 48: 347-55.
9. Bjornsson E, Sjoberg J, Ringstrom G et al. Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotilitylike dyspepsia. Digestion 2003; 67: 209-17.
10. Feinle C, D'Amato M, Read NW. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996; 110: 1379-85.
11. Feinle C, Rades T, Otto B et al. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001; 120: 1100-7.
12. Schwartz MP, Samsom M, Smout AJ. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001; 96: 2596-602.
13. Pilichiewicz AN, Feltrin KL, Horowitz M et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastro enterol 2008; 103: 2613-23.
14. MacIntosh CG, Andrews JM, Jones KL et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 1999; 69: 999-1006.
15. Talley NJ, Haque M, Wyeth JW et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999; 13: 225-35.
16. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Ame J Gastroenterol 1999; 94: 2390-7.
17. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
18. Camilleri M, Zinsmeister AR, Greydanus MP et al. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991; 36: 609-15.
19. Rao SSC, Camilleri M, Hasler WL et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23: 8-23.
20. Frost G, Brynes AE, Ellis S et al. Nutritional influences on gut hormone release. Curr Opin Endocrinol Diabetes 2006; 13: 42-8.
21. Alzaid AA, Dinneen SF, Turk DJ et al. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 1994; 94: 2341-8.
22. Firth RG, Bell PM, Marsh HM et al. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 1986; 77: 1525-32.
23. McMahon MM, Schwenk WF, Haymond MW et al. Underestimation of glucose turnover measured with [6-3H]-and [6, 6-2H]-but not [6-14C] glucose during hyperinsulinemia in humans. Diabetes 1989; 38: 97-107.
24. Butler PC, Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 1991; 40: 73-81.
25. Rehfeld JF. Accurate measurement of cholecystokinin in plasma [see comment]. Clin Chem 1998; 44: 991-1001.
26. Pilichiewicz AN, Little TJ, Brennan IM et al. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. [in Mol Pharmacol 2012; 82:142]
27. American Journal of Physiology-Regulatory Integrative & Comparative Physiology 2006; 290: R668-77.
28. Caldarella MP, Azpiroz F, Malagelada JR. Selective effects of nutrients on gut sensitivity and refl exes. Gut 2007; 56: 37-42.
29. Feinle C, Christen M, Grundy D et al. Effects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans. Neurogastroenterol Motil 2002; 14: 205-13.
30. Pilichiewicz AN, Papadopoulos P, Brennan IM et al. Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2007; 293: R2170-R2178.
31. Chaikomin R, Doran S, Jones KL et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metabol 2005; 289: E504-E507.
32. Dailey MJ, Moran TH. Glucagon-like peptide 1 and appetite. Trends Endocrinol Metabol 2013; 24: 85-91.
33. Lacy BE, Carter J, Weiss JE et al. The effects of intraduodenal nutrient infusion on serum CCK, LES pressure, and gastroesophageal reflux. Neurogastroenterol Motil 2011; 23: 631-e256.
34. Edholm T, Degerblad M, Gryback P et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterol Motil 2010; 22: 1191-200e315.
35. Rayner CK, Samsom M, Jones KL et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371-81.
36. Lawaetz O, Blackburn AM, Bloom SR et al. Gut hormone profi le and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scand J Gastroenterol 1983; 18: 73-80.
37. Andreasen JJ, Orskov C, Holst JJ. Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion 1994; 55: 221-8.
38. Gebhard B, Holst JJ, Biegelmayer C et al. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 2001; 46: 1915-23.
39. Tack J, Arts J, Caenepeel P et al. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6: 583-90.
40. Koole C, Wootten D, Simms J et al. Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation. [erratum appears in Mol Pharmacol 2012; 82:142].
41. Mol Pharmacol 2011; 80: 486-97.
42. Delgado-Aros S, Kim DY, Burton DD et al. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 2002; 282: G424-G431.
43. Andrews CN, Bharucha AE, Camilleri M et al. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1359-G1365.
44. Farre R, Vanheel H, Vanuytsel T et al. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity. Gastroenterology 2013; 145: 566-73.
45. Delgado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia[see comment]. Gastroenterology 2004; 127: 1685-94.
46. Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 158-67.
47. Vanheel H, Vicario M, Vanuytsel T et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63: 262-71.
48. Walker MM, Warwick A, Ung C et al. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep 2011; 13: 323-30.